Summary of Conference Call on Anti-Aging Market and Swisse's Position Industry Overview - The anti-aging market in China has reached a scale of 17.2 billion yuan and is experiencing high double-digit growth annually, indicating a strong demand for anti-aging products among consumers, particularly in the elite and affluent segments [3][8][12] - The market includes various segments such as precision anti-aging, traditional Chinese medicine anti-aging, and foods claiming anti-aging effects [3][8] Key Trends in Consumer Behavior - Post-pandemic, Chinese consumers have shifted from a passive approach to health, which was primarily about not being sick, to an active pursuit of health solutions, with a growing focus on quality of life [2][7] - The demographic focus has expanded from consumers aged 30 and above to include younger individuals around 20 years old, indicating a broader interest in health and wellness among younger generations [2][7] Swisse's Market Position and Strategy - Swisse entered the anti-aging market five years ago and has established a leading position through a science-driven approach, focusing on understanding consumer needs and providing high-quality products [6][12] - The company has launched the Swisse Plus brand, targeting the ultra-high-end cellular nutrition anti-aging market, with products developed by a Nobel Prize-winning team [12][13] Product Development and Safety - Swisse Plus's flagship product, the "Newborn Bottle," contains key ingredients such as NR, ergothioneine, and PQQ, which have undergone extensive safety and efficacy testing, including over 520,000 formulation tests and 269 efficacy tests [12][13] - The product has received multiple international certifications for safety and has been validated through various tests, ensuring it is suitable for long-term use [13] Future Market Directions - The anti-aging market is expected to evolve towards age-specific solutions, with products tailored to the needs of different age groups, such as skin-focused solutions for those around 30 and more comprehensive repair solutions for those over 40 [15] - Swisse aims to address these varying needs by designing products that cater to the specific concerns of different age demographics [15] Popular Anti-Aging Ingredients - Current popular anti-aging ingredients include NR, NMN, PQQ, ergothioneine, astaxanthin, and active peptides, each targeting different aspects of aging [10][11] Consumer Demand Characteristics - High-quality consumers are willing to pay a premium for anti-aging products and are proactive in seeking reliable brands, emphasizing the importance of safety and efficacy in product offerings [9]

Group 1: Electric Power Equipment and New Energy - In Q1 2025, European BEV sales from companies like Renault, Volkswagen, and BMW saw significant growth, with Renault's BEV sales up by 88%, Volkswagen's by 113%, and BMW's by 64% [5][6] - Chinese automakers are increasing exports to Europe, with BYD's sales reaching 14,000 units, a 124% year-on-year increase, while MG's sales dropped by 47% [6] - European automakers are set to launch new electric vehicle models from 2025 to 2026, which is expected to solidify the trend towards electrification [7] - The pressure from carbon emission assessments is high, but the introduction of new models is anticipated to help exceed targets by 2027 [8] Group 2: Social Services - Recent research highlights hyaluronic acid (HA) as a key factor in the aging process, marking a shift towards systemic interventions in anti-aging strategies [10][11] - Huaxi Biological Technology has positioned itself at the forefront of ECM research, with two new anti-aging products recently approved, indicating a shift from local to systemic interventions in anti-aging [12][13] Group 3: Media - Bilibili reported a revenue of 7.003 billion yuan in Q1 2025, a 23.6% year-on-year increase, with a net profit of 362 million yuan, indicating a turnaround from losses [15][16] - The platform's DAU reached 107 million, a 4.5% increase year-on-year, with MAU hitting a record high of 368 million, suggesting strong user growth [17][19] - The company is expected to benefit from the growth in gaming, membership, advertising, and IP monetization, driving future revenue growth [15][19] Group 4: Pharmaceuticals - The company has increased its stake in AR882 to 100%, enhancing its market position for this gout treatment, which shows significant potential for growth [21][22] - AR882 has demonstrated superior efficacy and safety in clinical trials, positioning it as a best-in-class product in the market [22][23] - The company is increasing its R&D investment, with a pipeline of 15 innovative drugs showing promising early-stage results [23]